Full Text View
Tabular View
No Study Results Posted
Related Studies
Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer
This study is ongoing, but not recruiting participants.
Study NCT00112996   Information provided by National Cancer Institute (NCI)
First Received: June 2, 2005   Last Updated: November 16, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurotoxicity
Additional conditions recognized in this trial
Neurotoxicity Syndromes
Peripheral Nervous System Diseases
More general conditions related to this trial
Disorders of Environmental Origin
Nervous System Diseases
Neuromuscular Diseases
Poisoning
Interventions listed in this trial
alpha-lipoic acid
placebo
Additional drug interventions recognized in this trial
Thioctic Acid
More general drug interventions related to this trial
Antioxidants
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Vitamin B Complex
Vitamins
Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services